<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-22T07:29:41+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>为什么HPMCAS被广泛用于喷雾干燥分散体SDD的设计？</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/WcCuC1AEgv7cL-LDcgL_JQ</id>
    <link href="https://mp.weixin.qq.com/s/WcCuC1AEgv7cL-LDcgL_JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>韩国特应性皮炎新药寻求中国合作伙伴</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/LzMOxbhI1dbex0fcXqF8pA</id>
    <link href="https://mp.weixin.qq.com/s/LzMOxbhI1dbex0fcXqF8pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球11月批准的新药</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/fpixRFQLnIuCfv3lwdwzUg</id>
    <link href="https://mp.weixin.qq.com/s/fpixRFQLnIuCfv3lwdwzUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物共晶及其表征方法</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/V4fB8sViang37eTO1WxNZw</id>
    <link href="https://mp.weixin.qq.com/s/V4fB8sViang37eTO1WxNZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“替代对照品法”在有关物质测定中的应用</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/RWnISGWMZ2bJ5kPXkt-dzg</id>
    <link href="https://mp.weixin.qq.com/s/RWnISGWMZ2bJ5kPXkt-dzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【12-26北京见】药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/X5ugcWmxgrr0aQIjAkC58g</id>
    <link href="https://mp.weixin.qq.com/s/X5ugcWmxgrr0aQIjAkC58g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我姓“炎”</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/6tYtMiMdy-rUiOahDWPLTg</id>
    <link href="https://mp.weixin.qq.com/s/6tYtMiMdy-rUiOahDWPLTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仿制原料药小试开发合成与分析该如何做</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/MTqrGmNlpY8rDPGFYyL59w</id>
    <link href="https://mp.weixin.qq.com/s/MTqrGmNlpY8rDPGFYyL59w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准新型口服GnRH受体阻断剂用于前列腺癌治疗</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/IZ-rdT-zs8_22V7NFct-rg</id>
    <link href="https://mp.weixin.qq.com/s/IZ-rdT-zs8_22V7NFct-rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TAGRISSO®:FDA批准了最常见类型肺癌的首个辅助疗法</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/vHHOHvcdGkWV8wO8iiZLUw</id>
    <link href="https://mp.weixin.qq.com/s/vHHOHvcdGkWV8wO8iiZLUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年最后一次开放加群，有加群需求而未进群的朋友抓住机会</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/NGifAS9KGXXz9YtnABT5HQ</id>
    <link href="https://mp.weixin.qq.com/s/NGifAS9KGXXz9YtnABT5HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title>
    <updated>2020-12-19T23:19:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/ZgZ5u_XOSb3jAK8jCB5L7A</id>
    <link href="https://mp.weixin.qq.com/s/ZgZ5u_XOSb3jAK8jCB5L7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药事纵横广告投放须知</title>
    <updated>2020-12-19T23:19:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/cljdDY32Map21FPrqkJfaw</id>
    <link href="https://mp.weixin.qq.com/s/cljdDY32Map21FPrqkJfaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GLP-1受体激动剂：能否成为未来降糖药的中流砥柱？</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/jk5GnwrfPm4VI1MQC_b8vw</id>
    <link href="https://mp.weixin.qq.com/s/jk5GnwrfPm4VI1MQC_b8vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精彩回顾 | 2020药物制剂前沿技术高峰论坛圆满落幕！</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/sRUiHfx-31GJ70QV0ACS1A</id>
    <link href="https://mp.weixin.qq.com/s/sRUiHfx-31GJ70QV0ACS1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>气相色谱毛细管柱选择理论</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/kD2n_34ItSI4NBD_EK1L7A</id>
    <link href="https://mp.weixin.qq.com/s/kD2n_34ItSI4NBD_EK1L7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药临床前和初期临床研究阶段的制剂研究策略</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/qZBLxF4LHyh-eJ5XSpA5dA</id>
    <link href="https://mp.weixin.qq.com/s/qZBLxF4LHyh-eJ5XSpA5dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>低剂量口服固体制剂——处方开发的几点考虑</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/azZdR8JrnU62JAALPkRKYQ</id>
    <link href="https://mp.weixin.qq.com/s/azZdR8JrnU62JAALPkRKYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终巨献，不负众望！CPhI &amp; P-MEC China盛大启幕！</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/NEn7NrtH9ZXmBwA3u26Mww</id>
    <link href="https://mp.weixin.qq.com/s/NEn7NrtH9ZXmBwA3u26Mww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准今年第48个新药：用于光化性角化病治疗</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/TaF8z6MS3w9g5-hmQLbN2g</id>
    <link href="https://mp.weixin.qq.com/s/TaF8z6MS3w9g5-hmQLbN2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>